MAPT and early-onset autosomal dominant Alzheimer disease: In a triple-transgenic mouse model of Alzheimer's disease, repeated challenges with lipopolysaccharide were shown to exacerbate central nervous system inflammation and to cause increased tau phosphorylation [28].